Eubiotics Market is Growing at a CAGR of 7.06% from 2019 to 2025 | BIS Research

FREMONT, Calif. - June 25, 2021 - PRLog -- The nutrition and supplement industry is witnessing a rapid change due to rising urbanization and advanced animal feed solution in the present decade. With growth in the world population and rapid changes in comprehensive trade policies, pricing and supply chain of animal nutrition and supplements are adversely affected. Livestock producers are gradually inclining toward sustainable and natural animal feeds to enhance the animal overall performance to cater to the need for increasing animal product demand.

Read Report Overview at: https://bisresearch.com/industry-report/eubiotics-market.html

Eubiotics is considered to be one of the significantly advanced solutions in the livestock sector since the animal feed revolution. Eubiotics products and ingredients-based solutions enable the livestock farmers to effectively manage the animals gut health, immunity, yield, and overall performance, among others. The livestock farming industry has been witnessing a revolutionary phase, owing to the introduction of eubiotics in farming in the past decade. Integration of eubiotics into livestock farming has led to an increase in the animal yield, and it also manages the gut health effectively. Earlier, the livestock farmers used antibiotics growth promoters to maintain their livestock's health.

Europe generated the highest revenue of $1,572.0 million in 2019. The high revenue generation was majorly credited to a favorable growth rate of adoption of eubiotics products such as probiotics, prebiotics, organic acid, and essential oils. Rapidly increasing demand for high-quality meat and animal produce propagate the use of these products. The region is a well-known producer for milk-based products. Also, the rapidly increasing disease in cattle, aquaculture, swine, and poultry, among others, increases the need for eubiotics products for healthy production.

Get the Sample Report at: https://bisresearch.com/requestsample?id=983&type=dow...

The competitive landscape for the eubiotics market demonstrates an inclination of companies toward the adoption of strategies such as product launch and development and partnerships, collaborations, and joint ventures. The major established players in the market are focusing on business expansion and contracts to introduce new advanced solutions further on the existing product portfolio and to increase their global footprints in countries across the world. Novus International, Inc. (U.S.), Koninklijke DSM N.V. (Netherlands), Chr. Hansen Holding A/S (Denmark), Kemin Industries, Inc. (U.S.), Nestle Health Science (Switzerland), DuPont de Nemours, Inc. (U.S.), LESAFFRE (France), BENEO GmbH (Germany), Lallemand, Inc. (Canada) and Yara International ASA (Norway) are some of the prominent players in the eubiotics market.